Telemus Capital, LLC Bausch Health Companies Inc. Transaction History

Telemus Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 06, 2022	SELL	$21.6 - $27.79 $864 - $1,111	-40 Reduced 0.35%	11,375 $260,000
Q4 2021 Feb 01, 2022	SELL	$23.0 - $29.01 $2,990 - $3,771	-130 Reduced 1.13%	11,415 $315,000
Q3 2021 Oct 27, 2021	SELL	$25.04 - $30.06 $35,056 - $42,084	-1,400 Reduced 10.81%	11,545 $322,000
Q2 2021 Aug 09, 2021	SELL	$27.43 - $32.7 $20,572 - $24,525	-750 Reduced 5.48%	12,945 $380,000
Q1 2021 Apr 20, 2021	SELL	$21.37 - $34.38 $27,652 - $44,487	-1,294 Reduced 8.63%	13,695 $432,000
Q4 2020 Jan 28, 2021	SELL	$15.31 - $21.12 $23,898 - $32,968	-1,561 Reduced 9.43%	14,989 $311,000
Q3 2020 Nov 02, 2020	BUY	$14.88 - $20.13 $246,264 - $333,151	16,550 New	16,550 $283,000

255

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $3.07B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Telemus Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Telemus Capital, LLC with notifications on news.